Eevia Health Plc receives multiple sales orders for c. KSEK 1 045 (KEUR 90)
Eevia Health ("Eevia" or "The Company") received several sales orders for pine bark, bilberry, and lingonberry extracts totaling KSEK 1 045 (KEUR 90) from various European and Australian customers.
The sales orders are for the following ingredient products: Fenoprolic 70 Organic (Pine bark extract) – KEUR 17, Feno-Myrtillus 25 Organic (Bilberry Extract) – KEUR 46, and Lingonberry Extract with Acacia – KEUR 27.
The orders came from several European customers with consumer brands in foods and drinks, as well as supplements. This included one order that came via our distributor in DAHC countries, Breko of Germany. One order was for a first delivery to a European company selling pet foods. The order for Lingonberry extract was from an Australian company via our distributor Ingredient Plus.
Eevia has the product in stock, so it can be delivered fast. Except for the Pet food company, these are repeat orders. Eevia expects further repeat orders in the future from the same customers.
For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc
Email: stein.ulve@eeviahealth.com or investor@eeviahealth.com
Telephone: +358 400 22 5967
INFORMATION ABOUT EEVIA HEALTH PLC
Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients in dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.
Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia’s other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested in a sustainable fashion.
Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.
To learn more, please visit www.eeviahealth.com or follow Eevia Health on LinkedIn@EeviaHealth.